These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25174072)

  • 1. FDA investigation focuses on compounded drugs.
    J Am Vet Med Assoc; 2014 Jul; 245(1):26. PubMed ID: 25174072
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug treatment approved for equine neurological disease.
    FDA Consum; 2001; 35(5):6. PubMed ID: 11697099
    [No Abstract]   [Full Text] [Related]  

  • 3. Compounding of drugs in equine practice.
    Lenz TR; Kanara EW; Becht JL
    J Am Vet Med Assoc; 1994 Jul; 205(2):207-9. PubMed ID: 7928577
    [No Abstract]   [Full Text] [Related]  

  • 4. Folate deficiency during treatment with orally administered folic acid, sulphadiazine and pyrimethamine in a horse with suspected equine protozoal myeloencephalitis (EPM).
    Piercy RJ; Hinchcliff KW; Reed SM
    Equine Vet J; 2002 May; 34(3):311-6. PubMed ID: 12108754
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis.
    Furr M; Kennedy T; MacKay R; Reed S; Andrews F; Bernard B; Bain F; Byars D
    Vet Ther; 2001; 2(3):215-22. PubMed ID: 19746664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short communication: evaluation of the kinetics of antibodies against Sarcocystis neurona in serum from seropositive healthy horses without neurological deficits treated with ponazuril paste.
    Pusterla N; Packham A; Wilson WD; White A; Bellamy P; Renier AC; Conrad PA
    Vet Rec; 2013 Sep; 173(10):249. PubMed ID: 23893215
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacology of nervous system diseases.
    Dowling PM
    Vet Clin North Am Equine Pract; 1999 Dec; 15(3):575-88. PubMed ID: 10589468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epizootic of equine protozoal myeloencephalitis on a farm.
    Fenger CK; Granstrom DE; Langemeier JL; Stamper S
    J Am Vet Med Assoc; 1997 Apr; 210(7):923-7. PubMed ID: 9096721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA seeks to clear up confusion about compounding.
    J Am Vet Med Assoc; 2003 Oct; 223(8):1103, 1106. PubMed ID: 14584731
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of the noninferiority analysis in clinical studies.
    Bermingham EC; del Castillo JR; Radecki SV
    Equine Vet J; 2014 Jul; 46(4):399-401. PubMed ID: 24909652
    [No Abstract]   [Full Text] [Related]  

  • 11. Compounded equine drugs seized from Kentucky pharmacy.
    Kuehn BM
    J Am Vet Med Assoc; 2004 Oct; 225(7):993-4. PubMed ID: 15515973
    [No Abstract]   [Full Text] [Related]  

  • 12. Congenital defects in newborn foals of mares treated for equine protozoal myeloencephalitis during pregnancy.
    Toribio RE; Bain FT; Mrad DR; Messer NT; Sellers RS; Hinchcliff KW
    J Am Vet Med Assoc; 1998 Mar; 212(5):697-701. PubMed ID: 9524643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protozoal encephalomyelitis in horses: 82 cases (1972-1986).
    Boy MG; Galligan DT; Divers TJ
    J Am Vet Med Assoc; 1990 Feb; 196(4):632-4. PubMed ID: 2303389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compounding of Veterinary Drugs for Equine Practitioners.
    Stanley SD; Moffitt K; Wiebe V
    Vet Clin North Am Equine Pract; 2017 Apr; 33(1):213-225. PubMed ID: 28325180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Judge allows bulk ingredients for compounding: ruling favors pharmacy, but FDA can still distinguish manufacturing, compounding.
    Cima G
    J Am Vet Med Assoc; 2011 Nov; 239(10):1266-68. PubMed ID: 22044321
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
    Williams KG
    J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningitis and encephalomyelitis in horses.
    Pellegrini-Masini A; Livesey LC
    Vet Clin North Am Equine Pract; 2006 Aug; 22(2):553-89, x. PubMed ID: 16882487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA-CVM asks for veterinary input on responsible compounding of drugs.
    Raef TA
    J Am Vet Med Assoc; 1990 Oct; 197(8):967. PubMed ID: 2243048
    [No Abstract]   [Full Text] [Related]  

  • 19. [Equine protozoal myeloencephalitis in the Netherlands? An overview].
    Goehring LS; Sloet van Oldruitenborgh-Oosterbaan MM
    Tijdschr Diergeneeskd; 2001 May; 126(10):346-51. PubMed ID: 11392988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protozoal encephalomyelitis in horses.
    Brown TT; Patton CS
    J Am Vet Med Assoc; 1977 Sep; 171(6):492. PubMed ID: 914682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.